These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Vasoactive intestinal polypeptide (VIP) and peptide histidine methionine (PHM) in human penile corpus cavernosum tissue and circumflex veins: localization and in vitro effects. Kirkeby HJ; Fahrenkrug J; Holmquist F; Ottesen B Eur J Clin Invest; 1992 Jan; 22(1):24-30. PubMed ID: 1348474 [TBL] [Abstract][Full Text] [Related]
23. Characterization of a novel prepro VIP derived peptide. Yiangou Y; Requejo F; Polak JM; Bloom SR Biochem Biophys Res Commun; 1986 Sep; 139(3):1142-9. PubMed ID: 3767995 [TBL] [Abstract][Full Text] [Related]
24. Analysis of peptide histidine-isoleucine/vasoactive intestinal polypeptide-immunoreactive neurons in the central nervous system with special reference to their relation to corticotropin releasing factor- and enkephalin-like immunoreactivities in the paraventricular hypothalamic nucleus. Hökfelt T; Fahrenkrug J; Ju G; Ceccatelli S; Tsuruo Y; Meister B; Mutt V; Rundgren M; Brodin E; Terenius L Neuroscience; 1987 Dec; 23(3):827-57. PubMed ID: 3125490 [TBL] [Abstract][Full Text] [Related]
25. Pituitary adenylate cyclase activating peptide: a novel vasoactive intestinal peptide-like neuropeptide in the gut. Sundler F; Ekblad E; Absood A; Håkanson R; Köves K; Arimura A Neuroscience; 1992; 46(2):439-54. PubMed ID: 1542417 [TBL] [Abstract][Full Text] [Related]
26. Peptide histidine-methionine immunoreactivity in plasma and tissue from patients with vasoactive intestinal peptide-secreting tumors and watery diarrhea syndrome. Yiangou Y; Williams SJ; Bishop AE; Polak JM; Bloom SR J Clin Endocrinol Metab; 1987 Jan; 64(1):131-9. PubMed ID: 3023426 [TBL] [Abstract][Full Text] [Related]
27. Immunochemical study on PHI/PHM with use of synthetic peptides. Yanaihara N; Yanaihara C; Nokihara K; Iguchi K; Fukata S; Tanaka M; Yamamoto Y; Mochizuki T Peptides; 1984; 5(2):247-54. PubMed ID: 6548021 [TBL] [Abstract][Full Text] [Related]
28. Cosecretion of peptide histidine methionine (PHM) and vasoactive intestinal peptide (VIP) in patients with VIP-producing tumors. Fahrenkrug J; Pedersen JH Peptides; 1986; 7(5):717-21. PubMed ID: 3797338 [TBL] [Abstract][Full Text] [Related]
29. Identification of a potential receptor for both peptide histidine isoleucine and peptide histidine valine. Tse DL; Pang RT; Wong AO; Chan SM; Vaudry H; Chow BK Endocrinology; 2002 Apr; 143(4):1327-36. PubMed ID: 11897689 [TBL] [Abstract][Full Text] [Related]
30. Variable distribution of three molecular forms of peptide histidine isoleucinamide in rat tissues: identification of the large molecular form as peptide histidine valine-(1-42). Cauvin A; Vandermeers A; Vandermeers-Piret MC; Robberecht P; Christophe J Endocrinology; 1989 Nov; 125(5):2645-55. PubMed ID: 2792003 [TBL] [Abstract][Full Text] [Related]
31. Variants of vasoactive intestinal peptide in mouse mast cells and rat basophilic leukemia cells. Wershil BK; Turck CW; Sreedharan SP; Yang J; An S; Galli SJ; Goetzl EJ Cell Immunol; 1993 Oct; 151(2):369-78. PubMed ID: 8402943 [TBL] [Abstract][Full Text] [Related]
32. Thrittene, homologous with somatostatin-28((1-13)), is a novel peptide in mammalian gut and circulation. Ensinck JW; Baskin DG; Vahl TP; Vogel RE; Laschansky EC; Francis BH; Hoffman RC; Krakover JD; Stamm MR; Low MJ; Rubinstein M; Otero-Corchon V; D'Alessio DA Endocrinology; 2002 Jul; 143(7):2599-609. PubMed ID: 12072392 [TBL] [Abstract][Full Text] [Related]
33. Down-regulation of vasoactive intestinal peptide and altered expression of its receptors in rat diabetic cardiomyopathy. Dvoráková MC; Pfeil U; Kuncová J; Svíglerová J; Galvis G; Krasteva G; König P; Grau V; Slavíková J; Kummer W Cell Tissue Res; 2006 Mar; 323(3):383-93. PubMed ID: 16344947 [TBL] [Abstract][Full Text] [Related]
34. Infusion of prepro-VIP derived peptides in man: effect on secretion of prolactin. Yiangou Y; Gill JS; Chrysanthou BJ; Burrin J; Bloom SR Neuroendocrinology; 1988 Dec; 48(6):615-8. PubMed ID: 3251160 [TBL] [Abstract][Full Text] [Related]
35. Evidence for common precursors but differential processing of VIP and PHM in VIP-producing tumors. Fahrenkrug J Peptides; 1985; 6(3):357-61. PubMed ID: 3840886 [TBL] [Abstract][Full Text] [Related]
36. Vasoactive intestinal peptide (VIP) and peptide histidine methionine (PHM) in human eccrine sweat glands: demonstration of innervation, specific binding sites and presence in secretions. Eedy DJ; Shaw C; Armstrong EP; Johnston CF; Buchanan KD Br J Dermatol; 1990 Jul; 123(1):65-76. PubMed ID: 2390496 [TBL] [Abstract][Full Text] [Related]
37. Effects of prepro-vasoactive intestinal peptide-derived peptides on the murine immune response. Yiangou Y; Serrano R; Bloom SR; Peña J; Festenstein H J Neuroimmunol; 1990; 29(1-3):65-72. PubMed ID: 2170441 [TBL] [Abstract][Full Text] [Related]
38. Distribution and characterization of endogenous benzodiazepine receptor ligand (endozepine)-like peptides in the rat gastrointestinal tract. Steyaert H; Tonon MC; Tong Y; Smihrouet F; Testart J; Pelletier G; Vaudry H Endocrinology; 1991 Oct; 129(4):2101-9. PubMed ID: 1915089 [TBL] [Abstract][Full Text] [Related]
39. On the immunocytochemical localization of the vasoactive intestinal polypeptide. Larsson LI; Polak JM; Buffa R; Sundler F; Solcia E J Histochem Cytochem; 1979 May; 27(5):936-8. PubMed ID: 479555 [TBL] [Abstract][Full Text] [Related]
40. The distribution and cellular origin of vasoactive intestinal polypeptide in the avian gastrointestinal tract and pancreas. Vaillant C; Dimaline R; Dockray GJ Cell Tissue Res; 1980; 211(3):511-23. PubMed ID: 7417998 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]